Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway

{{article.zuoZheEn}}

PDF(3154 KB)
PDF(3154 KB)
Protein Cell ›› 2018, Vol. 9 ›› Issue (9) : 770-784. DOI: 10.1007/s13238-017-0500-9
RESEARCH ARTICLE

Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Protein Cell, 2018, 9(9): 770‒784 https://doi.org/10.1007/s13238-017-0500-9

References

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(3154 KB)

Accesses

Citations

Detail

Sections
Recommended

/